Hysteroscopy and Endometrial Biopsy Guidelines

Indications for Hysteroscopy with Biopsy

The American College of Obstetricians and Gynecologists and the National Comprehensive Cancer Network recommend hysteroscopy with targeted biopsy for persistent or recurrent abnormal uterine bleeding despite negative office endometrial biopsy, which has a 10% false-negative rate 1, 2
Hysteroscopy with biopsy is indicated for postmenopausal bleeding with any endometrial thickness ≥4mm on transvaginal ultrasound, as recommended by the American College of Obstetricians and Gynecologists 2
The National Comprehensive Cancer Network recommends hysteroscopy with biopsy for suspected focal lesions, such as polyps, where blind biopsy techniques are unreliable, although the citation is not directly provided, it is implied through the recommendation for inadequate or non-diagnostic office endometrial biopsy in symptomatic patients 1, 2
Women on tamoxifen therapy with postmenopausal bleeding should undergo hysteroscopy with biopsy, as recommended by the American College of Obstetricians and Gynecologists 2
The National Comprehensive Cancer Network recommends annual endometrial biopsy screening starting at age 30-35 years for women with Lynch syndrome, who have a 30-60% lifetime risk of endometrial cancer 1, 3, 2

The American College of Obstetricians and Gynecologists recommends transvaginal ultrasound as the first-line assessment for abnormal uterine bleeding 2
Office endometrial biopsy (Pipelle/Vabra) is recommended if endometrial thickness ≥3-4mm or risk factors are present, as suggested by the American College of Obstetricians and Gynecologists 2
If office biopsy is negative but symptoms persist, or if biopsy is inadequate/non-diagnostic, the National Comprehensive Cancer Network recommends proceeding to hysteroscopy WITH directed biopsy under anesthesia 1, 2

The National Comprehensive Cancer Network advises against accepting a negative office endometrial biopsy as definitive in a symptomatic patient, especially postmenopausal women, due to the 10% false-negative rate 1, 2
The American College of Obstetricians and Gynecologists recommends against proceeding directly to hysterectomy without tissue diagnosis, as this exposes patients to unnecessary surgical risk if pathology is benign 2

The American College of Radiology recommends that transvaginal ultrasound (TVUS) with Doppler should be performed first to confirm the presence of the polyp and assess endometrial thickness, as MRI is not the standard initial imaging modality for suspected endometrial polyps 4, 5
Adding color Doppler imaging increases diagnostic accuracy by identifying the vascular pedicle of polyps (specificity 62-98%, negative predictive value 50-94%) 5

The National Comprehensive Cancer Network recommends that tamoxifen use is a risk factor for malignancy in polyps 6
The National Comprehensive Cancer Network also recommends that Lynch syndrome (30-60% lifetime endometrial cancer risk) is a risk factor for malignancy in polyps 6
Abnormal bleeding is present in 90% of endometrial cancer cases, according to the National Comprehensive Cancer Network 6

The American College of Radiology recommends that MRI findings alone without tissue diagnosis are not reliable to distinguish benign from malignant polyps 7
The National Comprehensive Cancer Network recommends that a negative office endometrial biopsy should not be accepted as reassuring if a polyp is visualized on imaging, as blind biopsy techniques miss polyps 6